Punjab wicket-keeper batsman Abhishek Gupta was today handed a retrospective eight-month suspension for an "inadvertent" doping violation.
The 27-year-old's suspension started from January 15 and will end on September 14.
"Gupta had inadvertently ingested a prohibited substance (terbutaline), which can be commonly found in cough syrups," said the BCCI in a statement.
The Board said it was satisfied with Gupta's explanation.
"Gupta had provided a urine sample as part of the BCCI's anti-doping testing program during a domestic T-20 competition on 15th January in New Delhi. His sample was subsequently tested and found to contain Terbutaline.
"Terbutaline, a specified substance, is prohibited both In & Out of Competition in the WADA Prohibited List of Substances."
"Gupta responded to the charge by admitting the ADRV but asserting that it was inadvertent, being caused by his ingestion of medication containing Terbutaline that had been prescribed for him by his doctor."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
